Skip to main content

Advertisement

Log in

ASO Author Reflections: ADH Upgrade Rate is Not Elevated by Presence of Ipsilateral Concurrent Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Racz JM, Carter JM, Degnim AC. Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations. Ann Surg Oncol. 2017;24(10):2848–54. https://doi.org/10.1245/s10434-017-5978-0.

    Article  PubMed  Google Scholar 

  2. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast—risk assessment and management options. N Engl J Med. 2015;372(1):78–89. https://doi.org/10.1056/nejmsr1407164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Amin AL, Fan F, Winblad OD, Larson KE, Wagner JL. Ipsilateral and concurrent breast cancer and atypical ductal hyperplasia: does atypia also need surgical excision? Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08896-7.

    Article  PubMed  Google Scholar 

  4. Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open. 2019;9(3):e026797. https://doi.org/10.1136/bmjopen-2018-026797.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda L. Amin MD, MS.

Ethics declarations

Disclosures

All authors have no commercial interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amin, A.L., Wagner, J.L. ASO Author Reflections: ADH Upgrade Rate is Not Elevated by Presence of Ipsilateral Concurrent Breast Cancer. Ann Surg Oncol 27 (Suppl 3), 705–706 (2020). https://doi.org/10.1245/s10434-020-08947-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08947-z

Navigation